Alexandre Harlé

1.3k total citations
70 papers, 805 citations indexed

About

Alexandre Harlé is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Alexandre Harlé has authored 70 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 38 papers in Cancer Research and 24 papers in Molecular Biology. Recurrent topics in Alexandre Harlé's work include Cancer Genomics and Diagnostics (33 papers), Genetic factors in colorectal cancer (16 papers) and Colorectal Cancer Treatments and Studies (10 papers). Alexandre Harlé is often cited by papers focused on Cancer Genomics and Diagnostics (33 papers), Genetic factors in colorectal cancer (16 papers) and Colorectal Cancer Treatments and Studies (10 papers). Alexandre Harlé collaborates with scholars based in France, Germany and Belgium. Alexandre Harlé's co-authors include Jean‐Louis Merlin, Pauline Gilson, Agnès Leroux, Marie Husson, Julia Salleron, Pascal Génin, Valentin Harter, Pierre Filhine-Trésarrieu, Étienne Rouleau and Florence Koeppel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Alexandre Harlé

65 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Harlé France 17 377 377 349 191 165 70 805
Ghassan Allo Canada 16 194 0.5× 227 0.6× 334 1.0× 169 0.9× 172 1.0× 29 796
Yoshiatsu Sagara Japan 14 484 1.3× 337 0.9× 246 0.7× 156 0.8× 101 0.6× 26 804
M R Emmert-Buck United States 13 245 0.6× 459 1.2× 642 1.8× 171 0.9× 197 1.2× 19 1.1k
Eloise Scarano Italy 11 489 1.3× 408 1.1× 209 0.6× 115 0.6× 106 0.6× 17 690
Isabelle Vanden Bempt Belgium 16 451 1.2× 261 0.7× 326 0.9× 149 0.8× 128 0.8× 48 815
Chit Chow Hong Kong 21 646 1.7× 396 1.1× 534 1.5× 184 1.0× 568 3.4× 53 1.4k
Nadia Barraco Italy 19 495 1.3× 332 0.9× 402 1.2× 106 0.6× 337 2.0× 45 1.0k
Yi Zeng China 14 442 1.2× 164 0.4× 285 0.8× 96 0.5× 56 0.3× 27 802
Federico Sandoval France 9 777 2.1× 147 0.4× 306 0.9× 114 0.6× 179 1.1× 16 1.1k
Ecaterina E. Dumbrava United States 17 647 1.7× 194 0.5× 379 1.1× 89 0.5× 218 1.3× 115 1.0k

Countries citing papers authored by Alexandre Harlé

Since Specialization
Citations

This map shows the geographic impact of Alexandre Harlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Harlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Harlé more than expected).

Fields of papers citing papers by Alexandre Harlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Harlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Harlé. The network helps show where Alexandre Harlé may publish in the future.

Co-authorship network of co-authors of Alexandre Harlé

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Harlé. A scholar is included among the top collaborators of Alexandre Harlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Harlé. Alexandre Harlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilson, Pauline, et al.. (2025). A Novel Droplet Digital PCR Assay for BRCA1 and RAD51C Methylation. Journal of Molecular Diagnostics. 27(10). 1026–1036.
2.
Boidot, Romain, et al.. (2025). Decoding mutational signatures in breast cancer: Insights from a multi-cohort study. Translational Oncology. 53. 102315–102315. 1 indexed citations
3.
Merlin, Jean‐Louis, et al.. (2025). Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics. Biomarker Research. 13(1). 31–31. 8 indexed citations
4.
Gilson, Pauline, et al.. (2024). Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?. Clinical and Experimental Medicine. 24(1). 2–2. 4 indexed citations
5.
François, Aurélie, et al.. (2024). DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib. Cell Death Discovery. 10(1). 411–411. 3 indexed citations
6.
Lambert, Aurélien, Julia Salleron, Alexandre Harlé, et al.. (2024). Impact of Positive Resection Margins on Recurrence and Survival After Resection and Adjuvant Chemotherapy in Pancreatic Cancer. Annals of Surgery. 283(4). 651–658. 1 indexed citations
7.
Harlé, Alexandre, Marie Husson, Catherine Michel, et al.. (2024). 776P Liquid biopsy for the determination of homologous recombination deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study. Annals of Oncology. 35. S584–S584. 1 indexed citations
8.
Merlin, Jean‐Louis, et al.. (2023). Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS). Biomedicines. 11(12). 3164–3164. 2 indexed citations
9.
10.
Gilson, Pauline, et al.. (2023). Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers. Scientific Reports. 13(1). 12909–12909. 2 indexed citations
11.
Gilson, Pauline, Jean‐Louis Merlin, & Alexandre Harlé. (2022). Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy. Cancers. 14(6). 1384–1384. 65 indexed citations
12.
François, Aurélie, Aurélien Lambert, Stéphanie Grandemange, et al.. (2022). DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy. Frontiers in Oncology. 12. 1052163–1052163. 8 indexed citations
13.
Diop, Mamadou, Gilles Dolivet, Frédéric Marchal, et al.. (2021). A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization. Clinical Cancer Research. 27(19). 5307–5316. 28 indexed citations
14.
Merlin, Jean‐Louis, et al.. (2021). Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Pharmaceuticals. 14(8). 740–740. 21 indexed citations
15.
Koeppel, Florence, et al.. (2020). Comparison of Pathogenicity Prediction Tools on Somatic Variants. Journal of Molecular Diagnostics. 22(12). 1383–1392. 23 indexed citations
16.
Husson, Marie, Céline Gavoille, Aurélien Lambert, et al.. (2020). Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer. PLoS ONE. 15(1). e0227294–e0227294. 11 indexed citations
17.
Broséus, Julien, et al.. (2018). Clinical Interest of Circulating Tumor DNA in Oncology. Archives of Medical Research. 49(5). 297–305. 8 indexed citations
18.
Rauch, Philippe, Jean‐Louis Merlin, Julia Salleron, et al.. (2016). Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients. International Journal of Surgery. 33. 177–181. 10 indexed citations
19.
20.
Harlé, Alexandre, et al.. (2013). Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: Correlation with clinicopathological criteria. Oncology Reports. 29(3). 1043–1052. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghassan Allo Breakdown of academic impact, for papers by Yoshiatsu Sagara Breakdown of academic impact, for papers by M R Emmert-Buck Breakdown of academic impact, for papers by Eloise Scarano Breakdown of academic impact, for papers by Isabelle Vanden Bempt Breakdown of academic impact, for papers by Chit Chow Breakdown of academic impact, for papers by Nadia Barraco Breakdown of academic impact, for papers by Yi Zeng Breakdown of academic impact, for papers by Federico Sandoval Breakdown of academic impact, for papers by Ecaterina E. Dumbrava
Rankless by CCL
2026